ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification and characterization of a novel adiponectin receptor agonist adipo anti-inflammation agonist and its anti-inflammatory effects in vitro and in vivo

Qiu, Wei; Wu, Hongle; Hu, Zhekai; Wu, Xingwen; Tu, Maxwell; Fang, Fuchun; Zhu, Xiaofang; Liu, Yao; Lian, Junxiang; Valverde, Paloma; Van Dyke, Thomas; Steffensen, Bjorn; Dong, Lily Q.; Tu, Qisheng*; Zhou, Xuedong*; Chen, Jake*南方医科大学; 四川大学; jk
British Journal of Pharmacology2021-1DOI: 10.1111/bph.15277
19被引8阅读
引用收藏
分享

摘要

Background and Purpose Adiponectin (APN) is an adipokine secreted from adipocytes that binds to APN receptors AdipoR1 and AdipoR2 and exerts an anti-inflammatory response through mechanisms not fully understood. There is a need to develop small molecules that activate AdipoR1 and AdipoR2 and to be used to inhibit the inflammatory response in lipopolysaccharide (LPS)-induced endotoxemia and other inflammatory disorders. @@@ Experimental Approach We designed 10 new structural analogues of an AdipoR agonist, AdipoRon (APR), and assessed their anti-inflammatory properties. Bone marrow-derived macrophages (BMMs) and peritoneal macrophages (PEMs) were isolated from mice. Levels of pro-inflammatory cytokines were measured by reverse transcription and real-time quantitative polymerase chain reaction (qRT-PCR), enzyme-linked immunosorbent assay (ELISA) and microarray in LPS-induced endotoxemia mice and diet-induced obesity (DIO) mice in which systemic inflammation prevails. Western blotting, immunohistochemistry (IHC), siRNA interference and immunoprecipitation were used to detect signalling pathways. @@@ Key Results A novel APN receptor agonist named adipo anti-inflammation agonist (AdipoAI) strongly suppresses inflammation in DIO and endotoxemia mice, as well as in cultured macrophages. We also found that AdipoAI attenuated the association of AdipoR1 and APPL1 via myeloid differentiation marker 88 (MyD88) signalling, thus inhibiting activation of nuclear factor kappa B (NF-kappa B), mitogen-activated protein kinase (MAPK) and c-Maf pathways and limiting the production of pro-inflammatory cytokines in LPS-induced macrophages. @@@ Conclusion and Implications AdipoAI is a promising alternative therapeutic approach to APN and APR to suppress inflammation in LPS-induced endotoxemia and other inflammatory disorders via distinct signalling pathways.

学科与关键词

关键词
AdipoAIAPPL1c&#8208MafinflammationlipopolysaccharideMyD88
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
British Journal of Pharmacology
发表日期
2021-01
卷期
第 178 卷, 第 2 期
页码
280-297
DOI
10.1111/bph.15277
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81400502, 31200985]; Tufts University Awards [D740207]; National Institutes of Health (NIH) [R01DE26507, R01DE25681, R01DE21464]

作者

  • Q

    Qiu, Wei (第一作者)

    southern med univ · sichuan univ

  • W

    Wu, Hongle

    sichuan univ

查看全部 16 位作者收起作者
  • H

    Hu, Zhekai

  • W

    Wu, Xingwen

  • T

    Tu, Maxwell

  • F

    Fang, Fuchun

    southern med univ

  • Z

    Zhu, Xiaofang

  • L

    Liu, Yao

    sichuan univ

  • L

    Lian, Junxiang

    sichuan univ

  • V

    Valverde, Paloma

  • V

    Van Dyke, Thomas

  • S

    Steffensen, Bjorn

  • D

    Dong, Lily Q.

  • T

    Tu, Qisheng (通讯)

  • Z

    Zhou, Xuedong (通讯)

    sichuan univ

  • C

    Chen, Jake (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417